Author

E. C. Leuthardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. H. Kim· 2 shared A. J. Livingstone· 2 shared A. Z. Wang· 2 shared G. P. Dunn· 2 shared M. O. Schaettler· 2 shared M. R. Chicoine· 2 shared T. M. Johanns· 2 shared A. A. Petti· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. H. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population

A. Z. Wang, B. L. Mashimo, M. O. Schaettler, N. D. Sherpa, L. A. Leavitt, A. J. Livingstone, S. M. Khan, M. Li, M. Anzaldua-Campos, J. D. Bradley, E. C. Leuthardt, A. H. Kim, J. L. Dowling, M. R. Chicoine, P. S. Jones, , G. P. Dunn

The paper analyzes TILs in GBM using CITE-seq and scRNA-seq to show that CD8+ T cells are predominantly clonally expanded GZMK+ effector cells, lacking canonical exhaustion.

bioRxiv · Aug 25, 2023 · PreprintImmunology

The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive anti-tumor immunity in the brain

J. A. Bowman-Kirigin, B. T. Saunders, R. Desai, A. Z. Wang, M. O. Schaettler, C. J. Liu, A. J. Livingstone, D. K. Kobayashi, V. Durai, N. M. Kretzer, G. J. Zipfel, E. C. Leuthardt, J. W. Osbun, M. R. Chicoine, A. H. Kim, , G. P. Dunn

The paper identifies cDC1's role in priming CD8+ T cells and trafficking tumor antigens to drive anti-tumor immunity in the brain.

bioRxiv · Sep 13, 2021Immunology